Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GMP Oversight To Get FDA-Wide Coordination Under New Cmte.

This article was originally published in The Pink Sheet Daily

Executive Summary

The Council on Pharmaceutical Quality will oversee implementation of the initiative, which covers aseptic processing, quality systems, computerized systems in clinical trials, process analytical technologies and combination products.

You may also be interested in...



FDA Budget Request Proposes New User Fees For Reinspection Of Manufacturing Facilities

The agency also plans to increase drug safety and to fund the Critical Path initiative for the first time.

FDA Budget Request Proposes New User Fees For Reinspection Of Manufacturing Facilities

The agency also plans to increase drug safety and to fund the Critical Path initiative for the first time.

FDA Establishes New Office For “Risk-Based” CMC Review

The Office of New Drug Quality Assessment will replace the Office of New Drug Chemistry effective Nov. 1.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS060716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel